speb/financial-data huggingface dataset:
Financial ratios for 8214.T — annual report dated 2023-03-31
Total revenue: 1322597597.5975976
Gross profit: 522192192.19219226
Operating income: 76846846.84684685
Net income: 42282282.282282285
Capital expenditures: 31576576.57657658
Operating cash flow: 131193693.6936937
Depreciation & amortization: 69309309.30930932
Net tangible assets: 938145645.6456457
Owner earnings: 80015015.01501502
Return on net tangible assets (%): 8.52906106705292
Capex to operating income (%): 41.09026963657679
Buffett classification: The Good
Stock price: 5.50352852852853
P/E ratio: 10.954140966017402
Shares outstanding: 84158023
Book value: 992860360.3603605
P/B ratio: 0.466496698807628
Market cap (USD): 463166080.48506016
Debt to equity: 0.3984756028400971
Current ratio: 1.6120562735154589
Quick ratio: 1.2140315720595454
Effective tax rate (%): 29.175257731958766
Interest coverage ratio: 28.276243093922652
COGS to revenue (%): 60.51768178463984
Free cash flow (dilution-adjusted): 91043543.54354355
Buyback yield (%): 0
Retained earnings: 656411411.4114115
Inventory turnover: 5.477215515026972
Receivables turnover: 13.433734939759034
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.547606659729447
FCF margin (%): 6.883691888516774
Revenue growth (%): 4.174752032623397
Rule of 40 score: 11.05844392114017
Financial ratios for 8214.T — annual report dated 2024-03-31
Total revenue: 1239540412.044374
Gross profit: 507983359.7464342
Operating income: 91521394.61172742
Net income: 50132065.50449023
Capital expenditures: 67412836.76703645
Operating cash flow: 116171421.02482831
Depreciation & amortization: 64157422.08135235
Net tangible assets: 858326730.0581088
Owner earnings: 46876650.81880613
Return on net tangible assets (%): 5.461399392237566
Capex to operating income (%): 73.65800865800867
Buffett classification: The Good
Stock price: 6.766045958795563
P/E ratio: 11.358340129998684
Shares outstanding: 84158023
Book value: 905011885.8954041
P/B ratio: 0.6291818486516362
Market cap (USD): 569417051.419374
Debt to equity: 0.3517930757725001
Current ratio: 1.5774148138149142
Quick ratio: 1.1484081223364253
Effective tax rate (%): 38.97596656217346
Interest coverage ratio: 48.46153846153846
COGS to revenue (%): 59.017878071128735
Free cash flow (dilution-adjusted): 37638668.77971474
Buyback yield (%): 1.0170177302315018
Retained earnings: 612869783.4125726
Inventory turnover: 4.979817503483616
Receivables turnover: 12.156197383758581
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.513416815742397
FCF margin (%): 3.036501949753884
Revenue growth (%): -6.279853048583404
Rule of 40 score: -3.24335109882952
Financial ratios for 8214.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 905280851.6598964
Buffett classification: The Gruesome
Stock price: 7.615282252416304
Shares outstanding: 84158023
Book value: 953726012.0465051
P/B ratio: 0.6719824046479845
Market cap (USD): 640887098.9503431
Debt to equity: 0.30666137927489295
Current ratio: 1.5021646943895564
Quick ratio: 0.9950045514087165
Buyback yield (%): 0
Retained earnings: 647814820.0028015
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8214.T — annual report dated 2025-03-31
Total revenue: 1287849218.0189815
Gross profit: 539299558.8825023
Operating income: 104578264.93784253
Net income: 63988771.554605
Capital expenditures: 56189012.16414917
Operating cash flow: 145274695.89627054
Depreciation & amortization: 66842668.092501
Net tangible assets: 905206523.1920866
Owner earnings: 74642427.48295683
Return on net tangible assets (%): 8.245900307892231
Capex to operating income (%): 53.72914935770435
Buffett classification: The Good
Stock price: 8.30584146504478
P/E ratio: 10.923841481362023
Shares outstanding: 84158023
Book value: 949993316.4015505
P/B ratio: 0.7357980156084932
Market cap (USD): 699003197.0495924
Debt to equity: 0.2860740970043198
Current ratio: 1.5766093191380093
Quick ratio: 1.1275011357575997
Effective tax rate (%): 31.34189198881159
Interest coverage ratio: 61.36078431372549
COGS to revenue (%): 58.124013950012454
Free cash flow (dilution-adjusted): 73593102.52640021
Buyback yield (%): 0
Retained earnings: 655106269.2153455
Inventory turnover: 4.925803755992435
Receivables turnover: 12.971255469538878
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.580798359190345
FCF margin (%): 5.714419164659968
Revenue growth (%): 3.8973159330022775
Rule of 40 score: 9.611735097662246
Financial ratios for 8214.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 905206523.1920866
Buffett classification: The Gruesome
Stock price: 8.30584146504478
Shares outstanding: 84158023
Book value: 949993316.4015505
P/B ratio: 0.7357980156084932
Market cap (USD): 699003197.0495924
Debt to equity: 0.2860740970043198
Current ratio: 1.5766093191380093
Quick ratio: 1.1275011357575997
Buyback yield (%): 0
Retained earnings: 655106269.2153455
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8214.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.014323277055079
Shares outstanding: 84158023
Market cap (USD): 926943671.6798366
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8214.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 889051144.0107672
Buffett classification: The Gruesome
Stock price: 11.5314266487214
Shares outstanding: 84158023
Book value: 935316285.3297442
P/B ratio: 1.037576362506907
Market cap (USD): 970462069.1259085
Debt to equity: 0.2100037413301868
Current ratio: 1.5423678129672422
Quick ratio: 0.9016718771238278
Buyback yield (%): 0
Retained earnings: 638351278.6002692
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9795.T — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.709129891013042
Shares outstanding: 15494228
Market cap (USD): 227906612.2129712
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9795.T — annual report dated 2022-09-30
Total revenue: 94533303.33033302
Gross profit: 30712538.94620231
Operating income: 25315599.252232913
Net income: 17745959.980613444
Capital expenditures: 2452980.6826836527
Operating cash flow: 21191428.37360659
Depreciation & amortization: 3401820.951325902
Net tangible assets: 171470241.63954857
Owner earnings: 18694800.24925569
Return on net tangible assets (%): 10.902649970339722
Capex to operating income (%): 9.689601491330656
Buffett classification: The Great
Stock price: 10.789517413279789
P/E ratio: 9.42046770047705
Shares outstanding: 15494228
Book value: 171699577.6500727
P/B ratio: 0.9736497031578837
Market cap (USD): 167175242.81132728
Debt to equity: 0.016493894607632616
Current ratio: 4.763545263376516
Quick ratio: 4.746255094888237
Effective tax rate (%): 31.259619915608916
Interest coverage ratio: 4089.856823266219
COGS to revenue (%): 67.51140829292535
SG&A to revenue (%): 1.4565701183840416
Free cash flow (dilution-adjusted): 18556740.289413556
Buyback yield (%): 0.00031062176956822357
Retained earnings: 144717219.41424912
Inventory turnover: 261.13754320358095
Receivables turnover: 197.718412859315
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.320787853815894
FCF margin (%): 19.62984433598993
Rule of 40 score: 19.62984433598993
Financial ratios for 9795.T — annual report dated 2023-09-30
Total revenue: 96705557.78759876
Gross profit: 26782462.836480513
Operating income: 21376329.181732956
Net income: 16106280.969599571
Capital expenditures: 1255443.9533949378
Operating cash flow: 19085409.133520823
Depreciation & amortization: 3437371.099504486
Net tangible assets: 173222391.85750636
Owner earnings: 18288208.11570912
Return on net tangible assets (%): 10.557646687359618
Capex to operating income (%): 5.873056794371278
Buffett classification: The Great
Stock price: 10.595486808624614
P/E ratio: 10.192848907434875
Shares outstanding: 15494228
Book value: 173671132.9851346
P/B ratio: 0.945285987152938
Market cap (USD): 164168888.38382214
Debt to equity: 0.012024692891711677
Current ratio: 5.04482040895991
Quick ratio: 5.026066438975598
Effective tax rate (%): 26.246011900290224
Interest coverage ratio: 5762.348375451263
COGS to revenue (%): 72.30513928534037
SG&A to revenue (%): 1.2092432021918282
Free cash flow (dilution-adjusted): 15454258.738449177
Buyback yield (%): 2.171963924981435
Retained earnings: 150839828.5790813
Inventory turnover: 276.5296859276521
Receivables turnover: 173.71545419553502
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.992021499487933
FCF margin (%): 15.98073481194582
Revenue growth (%): 2.2978721580003443
Rule of 40 score: 18.278606969946164
Financial ratios for 9795.T — annual report dated 2024-09-30
Total revenue: 105749649.81089789
Gross profit: 30711451.183639165
Operating income: 24593612.55077742
Net income: 17569673.62375683
Capital expenditures: 1738555.820142877
Operating cash flow: 23694999.299621794
Depreciation & amortization: 3696526.1241070176
Net tangible assets: 182925549.79689032
Owner earnings: 19527643.92772097
Return on net tangible assets (%): 10.675186680812663
Capex to operating income (%): 7.0691355999585355
Buffett classification: The Great
Stock price: 12.847107438016529
P/E ratio: 11.329522451456949
Shares outstanding: 15494228
Book value: 183756919.7366578
P/B ratio: 1.083257229552995
Market cap (USD): 199056011.78512397
Debt to equity: 0.01126402051956539
Current ratio: 4.317013188276601
Quick ratio: 4.301565134530185
Effective tax rate (%): 29.482975941099156
Interest coverage ratio: 9216.472440944883
COGS to revenue (%): 70.958342426138
SG&A to revenue (%): 1.4088278411689301
Free cash flow (dilution-adjusted): 21081643.087267123
Buyback yield (%): 3.84928268919456
Retained earnings: 165659805.29485923
Inventory turnover: 291.9094896874915
Receivables turnover: 158.37102340070695
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.061400906660467
FCF margin (%): 19.935425909178363
Revenue growth (%): 9.352194672371681
Rule of 40 score: 29.287620581550044
Financial ratios for 9795.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 180470451.8112552
Buffett classification: The Gruesome
Stock price: 14.83304371073386
Shares outstanding: 15494228
Market cap (USD): 229826561.18807647
Buyback yield (%): 0
Retained earnings: 165536211.73639888
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9795.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 183710565.2759085
Buffett classification: The Gruesome
Stock price: 16.549057873485868
Shares outstanding: 15494228
Book value: 184539925.9757739
P/B ratio: 1.3894818398845945
Market cap (USD): 256414875.8769852
Debt to equity: 0.005187211599994792
Current ratio: 3.623961322570287
Quick ratio: 3.6080720315650763
Buyback yield (%): 0
Retained earnings: 168736621.80349934
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9795.T — annual report dated 2025-09-30
Total revenue: 106641224.76446837
Gross profit: 31638344.54912517
Operating income: 25438277.25437416
Net income: 18100127.86002692
Capital expenditures: 1845349.9327052492
Operating cash flow: 22765666.218034994
Depreciation & amortization: 3488169.5827725437
Net tangible assets: 183710565.2759085
Owner earnings: 19742947.510094214
Return on net tangible assets (%): 10.746767601766924
Capex to operating income (%): 7.254225253748022
Buffett classification: The Great
Stock price: 16.549057873485868
P/E ratio: 14.166467654809365
Shares outstanding: 15494228
Book value: 184539925.9757739
P/B ratio: 1.3894818398845945
Market cap (USD): 256414875.8769852
Debt to equity: 0.005187211599994792
Current ratio: 3.623961322570287
Quick ratio: 3.6080720315650763
Effective tax rate (%): 30.425433289169334
Interest coverage ratio: 4661.070283600494
COGS to revenue (%): 70.33197563231035
SG&A to revenue (%): 1.3252193522437152
Free cash flow (dilution-adjusted): 19969360.699865412
Buyback yield (%): 1.5675985415806049
Retained earnings: 168736621.80349934
Inventory turnover: 295.97227607085006
Receivables turnover: 166.10991614255764
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.404182083761315
FCF margin (%): 18.725742079547995
Revenue growth (%): 0.8430996747174145
Rule of 40 score: 19.56884175426541
Financial ratios for 9795.T — quarterly report dated 2025-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.246650855714378
Shares outstanding: 15494228
Market cap (USD): 236235084.59483367
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9878.T — annual report dated 2022-03-31
Total revenue: 63365956.40059007
Gross profit: 16157613.505982626
Operating income: 2226266.1858711685
Net income: 3979683.658416653
Capital expenditures: 2144402.556957876
Operating cash flow: -3072930.6671037534
Depreciation & amortization: 95697.42665136863
Net tangible assets: 8184338.633010983
Owner earnings: 1930978.528110146
Return on net tangible assets (%): 23.593580553004898
Capex to operating income (%): 96.32282835570904
Buffett classification: The Gruesome
Stock price: 8.140714636944764
P/E ratio: 6.559343778039997
Shares outstanding: 3206612
Book value: 8406253.073266678
P/B ratio: 3.1053208862362554
Market cap (USD): 26104113.243402727
Debt to equity: 1.7721576124734457
Current ratio: 1.0883254889528362
Quick ratio: 0.5713740401133709
Effective tax rate (%): -8.704655093292143
Interest coverage ratio: 6.592782254150081
COGS to revenue (%): 74.50110024503635
Free cash flow (dilution-adjusted): -3881675.1352237337
Buyback yield (%): 0
Retained earnings: 3979683.658416653
Inventory turnover: 3.7741576817640983
Receivables turnover: 10.009053815444043
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.595493615108115
FCF margin (%): -6.125805330995663
Rule of 40 score: -6.125805330995663
Financial ratios for 9878.T — annual report dated 2023-03-31
Total revenue: 52850938.438438445
Gross profit: 17528776.27627628
Operating income: 821411.4114114115
Net income: -348243.24324324325
Capital expenditures: 509879.87987987994
Operating cash flow: -6327102.102102103
Depreciation & amortization: 234129.12912912914
Net tangible assets: 6373566.066066067
Owner earnings: -623993.9939939941
Return on net tangible assets (%): -9.790343232123107
Capex to operating income (%): 62.07362994918291
Buffett classification: The Good
Stock price: 4.539039039039039
Shares outstanding: 3206612
Book value: 6535773.273273274
P/B ratio: 2.226964804695801
Market cap (USD): 14554937.051051052
Debt to equity: 3.2191967285613363
Current ratio: 1.1127027025456877
Quick ratio: 0.5039690862096912
Effective tax rate (%): 202.84453706988296
Interest coverage ratio: 2.3788837431783096
COGS to revenue (%): 66.83354297634361
Free cash flow (dilution-adjusted): -6883791.291291292
Buyback yield (%): 0
Retained earnings: 2533355.855855856
Inventory turnover: 2.2451057677166295
Receivables turnover: 8.32659532818501
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.2813908992596295
FCF margin (%): -13.024917805971665
Revenue growth (%): -16.594112295373968
Rule of 40 score: -29.619030101345633
Financial ratios for 9878.T — annual report dated 2024-03-31
Total revenue: 55997774.69624934
Gross profit: 18244545.694664553
Operating income: 971071.0512414158
Net income: 241983.62387744323
Capital expenditures: 355850.50184891705
Operating cash flow: 55579.7675647121
Depreciation & amortization: 318231.64289487584
Net tangible assets: 5030025.092445853
Owner earnings: 204364.76492340205
Return on net tangible assets (%): 4.062897523718506
Capex to operating income (%): 36.64515602581277
Buffett classification: The Good
Stock price: 5.659006867406234
P/E ratio: 74.98953457403265
Shares outstanding: 3206612
Book value: 5191745.905969359
P/B ratio: 3.495209445485974
Market cap (USD): 18146239.329107236
Debt to equity: 3.4422363202999615
Current ratio: 1.0611529429660687
Quick ratio: 0.45691609438365094
Effective tax rate (%): 42.73369378379223
Interest coverage ratio: 3.153268863777688
COGS to revenue (%): 67.41915943333628
Free cash flow (dilution-adjusted): -388061.2783940835
Buyback yield (%): 0
Retained earnings: 1496652.1394611727
Inventory turnover: 2.498845714765235
Receivables turnover: 8.096365262869467
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.68968548171361
FCF margin (%): -0.6929941064605829
Revenue growth (%): 5.954172907405191
Rule of 40 score: 5.261178800944608
Financial ratios for 9878.T — quarterly report dated 2024-09-30
Total revenue: 14015947.611710323
Gross profit: 4494880.235327076
Operating income: 6555.539991595461
Net income: -209546.15492365876
Capital expenditures: 0
Net tangible assets: 5407592.0997338565
Owner earnings: -209546.15492365876
Return on net tangible assets (%): -3.8750362649204244
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.916654993696596
Shares outstanding: 3206612
Book value: 5589550.357192881
P/B ratio: 2.820585538219419
Market cap (USD): 15765804.90264743
Debt to equity: 4.361010730807594
Current ratio: 1.088224281932218
Quick ratio: 0.47764370935131656
Interest coverage ratio: 0.07685360045980787
COGS to revenue (%): 67.93019377902326
Buyback yield (%): 0
Retained earnings: 1645405.5189802493
Inventory turnover: 0.5575976757893494
Receivables turnover: 1.8380177813699738
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.05218773086519563
Rule of 40 score: 0
Financial ratios for 9878.T — annual report dated 2025-03-31
Total revenue: 50089486.69963908
Gross profit: 15056222.430156395
Operating income: -1849913.1132201576
Net income: -3645080.871541238
Capital expenditures: 1452640.021387515
Operating cash flow: -717978.8798288999
Depreciation & amortization: 525370.939713942
Net tangible assets: 1463160.0053468787
Owner earnings: -4572349.953214811
Return on net tangible assets (%): -312.49828702984684
Buffett classification: The Gruesome
Stock price: 4.678518914583612
Shares outstanding: 3206612
Book value: 1559978.6124849617
P/B ratio: 9.616923446042057
Market cap (USD): 15002194.893730786
Debt to equity: 13.310213192575963
Current ratio: 0.9909190047534969
Quick ratio: 0.35636217857960867
Interest coverage ratio: -5.264455264759587
COGS to revenue (%): 69.94133878025279
Free cash flow (dilution-adjusted): -2208842.400748563
Buyback yield (%): 0
Retained earnings: -2334474.0008020317
Inventory turnover: 2.304457832013896
Receivables turnover: 14.54794613618143
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -23.35619582534496
FCF margin (%): -4.4097924460553095
Revenue growth (%): -10.550933548089708
Rule of 40 score: -14.960725994145017
Financial ratios for 9878.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.455577082756712
Shares outstanding: 3206612
Market cap (USD): 27113754.940492664
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9878.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 4933674.293405115
Buffett classification: The Gruesome
Stock price: 4.387617765814267
Shares outstanding: 3206612
Book value: 5007032.301480487
P/B ratio: 2.809925507193784
Market cap (USD): 14069387.779273218
Debt to equity: 4.109751426325019
Current ratio: 1.0950997287106075
Quick ratio: 0.5011662031428621
Buyback yield (%): 0
Retained earnings: -4325989.232839839
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACLS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 74.56
Shares outstanding: 30733897
Market cap (USD): 2291519360.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACLS — annual report dated 2022-12-31
Total revenue: 919998000
Gross profit: 401790000
Operating income: 212361000
Net income: 183079000
Capital expenditures: 0
Operating cash flow: 215607000
Depreciation & amortization: 11607000
Net tangible assets: 667256000
Owner earnings: 194686000
Return on net tangible assets (%): 29.17710743702567
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 79.36
P/E ratio: 13.322347543519465
Shares outstanding: 30733897
Book value: 667256000
P/B ratio: 3.6553317855815455
Market cap (USD): 2439042065.92
Debt to equity: 0.06955950939369597
Current ratio: 3.5370085277191174
Quick ratio: 2.5600849547821323
Effective tax rate (%): 10.643043658637772
Interest coverage ratio: 38.084827833572454
COGS to revenue (%): 56.32707897191081
R&D to revenue (%): 8.516975036902254
SG&A to revenue (%): 12.073178419953088
Free cash flow (dilution-adjusted): 191480000
Buyback yield (%): 2.3572779167428193
Retained earnings: 118892000
Inventory turnover: 2.13776886710725
Receivables turnover: 5.418988885158417
Capitalized R&D asset: 78356000
ROCI (R&D-adjusted, %): 31.355528826688317
FCF margin (%): 20.81308872410592
Rule of 40 score: 20.81308872410592
Financial ratios for ACLS — annual report dated 2023-12-31
Total revenue: 1130604000
Gross profit: 491301000
Operating income: 265795000
Net income: 246263000
Capital expenditures: 20656000
Operating cash flow: 156869000
Depreciation & amortization: 13069000
Net tangible assets: 864882000
Owner earnings: 238676000
Return on net tangible assets (%): 27.596365747003638
Capex to operating income (%): 7.771402772813635
Buffett classification: The Great
Stock price: 129.69
P/E ratio: 16.185456613173724
Shares outstanding: 30733897
Book value: 864882000
P/B ratio: 4.608581404087494
Market cap (USD): 3985879101.93
Debt to equity: 0.05224412116334945
Current ratio: 3.787727660111739
Quick ratio: 2.7128387501797433
Effective tax rate (%): 11.60664611143615
Interest coverage ratio: 49.70918271928184
COGS to revenue (%): 56.545262532239406
R&D to revenue (%): 8.57125925611443
SG&A to revenue (%): 11.3743627300098
Free cash flow (dilution-adjusted): 117944000
Buyback yield (%): 1.3171247460711866
Retained earnings: 319506000
Inventory turnover: 2.0859397941804088
Receivables turnover: 5.187113468279166
Capitalized R&D asset: 149405520
ROCI (R&D-adjusted, %): 26.545929786368603
Rosenberg metric: 1.1423630609015263
FCF margin (%): 10.431946110220732
Revenue growth (%): 22.89200628697019
Rule of 40 score: 33.32395239719092
Financial ratios for ACLS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 104.85
Shares outstanding: 30733897
Market cap (USD): 3222449100.45
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACLS — annual report dated 2024-12-31
Total revenue: 1017865000
Gross profit: 454654000
Operating income: 210794000
Net income: 200992000
Capital expenditures: 12181000
Operating cash flow: 140818000
Depreciation & amortization: 15809000
Net tangible assets: 1012790000
Owner earnings: 204620000
Return on net tangible assets (%): 20.203596007069578
Capex to operating income (%): 5.778627475165328
Buffett classification: The Great
Stock price: 69.87
P/E ratio: 10.68389479874821
Shares outstanding: 30733897
Book value: 1012790000
P/B ratio: 2.12025926736046
Market cap (USD): 2147377383.39
Debt to equity: 0.043122463689412416
Current ratio: 5.41440425593431
Quick ratio: 4.05442796426403
Effective tax rate (%): 12.716155536447884
Interest coverage ratio: 38.59282314170633
COGS to revenue (%): 55.332583397601844
R&D to revenue (%): 10.364537536903223
SG&A to revenue (%): 13.593452962819235
Free cash flow (dilution-adjusted): 107686000
Buyback yield (%): 2.8168779492549105
Retained earnings: 470318000
Inventory turnover: 1.995609885729471
Receivables turnover: 5.010435690060005
Capitalized R&D asset: 196282170
ROCI (R&D-adjusted, %): 16.650278759892924
Rosenberg metric: -0.3781666959043206
FCF margin (%): 10.579595525929273
Revenue growth (%): -9.971572716884072
Rule of 40 score: 0.6080228090452007
Financial ratios for ACLS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 69.87
Shares outstanding: 30733897
Market cap (USD): 2147377383.39
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACLS — quarterly report dated 2025-03-31
Total revenue: 192563000
Gross profit: 88768000
Operating income: 29159000
Net income: 28579000
Capital expenditures: 4960000
Operating cash flow: 39795000
Depreciation & amortization: 4309000
Net tangible assets: 1027238000
Owner earnings: 27928000
Return on net tangible assets (%): 2.718746775333467
Capex to operating income (%): 17.010185534483348
Buffett classification: The Great
Stock price: 49.67
P/E ratio: 13.353797053693272
Shares outstanding: 30733897
Book value: 1027238000
P/B ratio: 1.486074954382529
Market cap (USD): 1526552663.99
Debt to equity: 0.04217912499342898
Current ratio: 5.559395119029795
Quick ratio: 4.082876678145431
Effective tax rate (%): 13.616854068431872
Interest coverage ratio: 21.3306510607169
COGS to revenue (%): 53.90183991732576
R&D to revenue (%): 14.087856961098447
SG&A to revenue (%): 16.867726406422832
Free cash flow (dilution-adjusted): 29932000
Buyback yield (%): 1.1907876111190014
Retained earnings: 485673000
Inventory turnover: 0.35083657258745987
Receivables turnover: 1.167409320456626
Capitalized R&D asset: 27128000
ROCI (R&D-adjusted, %): 4.0470536770786225
FCF margin (%): 15.544003780580901
Rule of 40 score: 15.544003780580901
Financial ratios for ACLS — quarterly report dated 2025-06-30
Total revenue: 194544000
Gross profit: 87343000
Operating income: 28965000
Net income: 31376000
Capital expenditures: 1985000
Operating cash flow: 39727000
Depreciation & amortization: 4515000
Net tangible assets: 1022383000
Owner earnings: 33906000
Return on net tangible assets (%): 3.316369697070472
Capex to operating income (%): 6.853098567236319
Buffett classification: The Great
Stock price: 69.69
P/E ratio: 35.724214526394796
Shares outstanding: 30733897
Book value: 1022383000
P/B ratio: 2.094953928156082
Market cap (USD): 2141845281.9299998
Debt to equity: 0.042062514732737144
Current ratio: 6.010349675619823
Quick ratio: 4.255659008396054
Effective tax rate (%): 10.346601137240336
Interest coverage ratio: 21.376383763837637
COGS to revenue (%): 55.10372974751213
R&D to revenue (%): 13.9115058804178
SG&A to revenue (%): 16.096101653096472
Free cash flow (dilution-adjusted): 32321000
Buyback yield (%): 2.1167261885110205
Retained earnings: 487164000
Inventory turnover: 0.344955079030016
Receivables turnover: 1.4011999337371526
Capitalized R&D asset: 45239760
ROCI (R&D-adjusted, %): 3.1860022076188197
Rosenberg metric: -0.05252875258035978
FCF margin (%): 16.613722345587632
Revenue growth (%): 1.0287542258897089
Rule of 40 score: 17.642476571477342
Financial ratios for ACLS — quarterly report dated 2025-09-30
Total revenue: 213611000
Gross profit: 88806000
Operating income: 25020000
Net income: 25986000
Capital expenditures: 2015000
Operating cash flow: 45350000
Depreciation & amortization: 4328000
Net tangible assets: 1020144000
Owner earnings: 28299000
Return on net tangible assets (%): 2.7740201383334115
Capex to operating income (%): 8.053557154276579
Buffett classification: The Great
Stock price: 97.64
P/E ratio: 34.91764935339361
Shares outstanding: 30733897
Book value: 1020144000
P/B ratio: 2.941602070962531
Market cap (USD): 3000857703.08
Debt to equity: 0.041828408538402424
Current ratio: 4.945142696329948
Quick ratio: 3.3151933021423297
Effective tax rate (%): 13.810945273631841
Interest coverage ratio: 19.17241379310345
COGS to revenue (%): 58.426298271156455
R&D to revenue (%): 11.534986494141219
SG&A to revenue (%): 18.325835280018353
Free cash flow (dilution-adjusted): 37991000
Buyback yield (%): 1.0775252677530236
Retained earnings: 488771000
Inventory turnover: 0.38479444536939406
Receivables turnover: 1.446876100680051
Capitalized R&D asset: 51725120
ROCI (R&D-adjusted, %): 1.940991962774747
Rosenberg metric: 0.05405704995566066
FCF margin (%): 17.785132788105482
Revenue growth (%): 9.800867670038654
Rule of 40 score: 27.586000458144134
Financial ratios for ACLS — quarterly report dated 2025-12-31
Total revenue: 238330000
Gross profit: 111932000
Operating income: 36172000
Net income: 34297000
Capital expenditures: 2335000
Operating cash flow: -6567000
Depreciation & amortization: 4461000
Net tangible assets: 1034677000
Owner earnings: 36423000
Return on net tangible assets (%): 3.5202290183313245
Capex to operating income (%): 6.455269269047882
Buffett classification: The Great
Stock price: 80.34
P/E ratio: 20.535615071607978
Shares outstanding: 30733897
Book value: 1034677000
P/B ratio: 2.3864078209721487
Market cap (USD): 2469161284.98
Debt to equity: 0.04091035173295628
Current ratio: 4.7718405342507335
Quick ratio: 3.1073155924314477
Effective tax rate (%): 14.296066769953523
Interest coverage ratio: 27.0748502994012
COGS to revenue (%): 53.03486762052616
R&D to revenue (%): 12.640456509881256
SG&A to revenue (%): 19.147400662946335
Free cash flow (dilution-adjusted): -14007000
Buyback yield (%): 1.0218449541340662
Retained earnings: 503539000
Inventory turnover: 0.3841767727424698
Receivables turnover: 1.4145976649908891
Capitalized R&D asset: 55565920
ROCI (R&D-adjusted, %): 3.2004192630158155
Rosenberg metric: 0.9385551948051948
FCF margin (%): -5.877145134896992
Revenue growth (%): 11.571969608306688
Rule of 40 score: 5.694824473409696
Financial ratios for ACLS — annual report dated 2025-12-31
Total revenue: 839048000
Gross profit: 376848000
Operating income: 119315000
Net income: 120238000
Capital expenditures: 11295000
Operating cash flow: 118305000
Depreciation & amortization: 17613000
Net tangible assets: 1034677000
Owner earnings: 126556000
Return on net tangible assets (%): 12.231450008070151
Capex to operating income (%): 9.466538155303189
Buffett classification: The Great
Stock price: 80.34
P/E ratio: 20.535615071607978
Shares outstanding: 30733897
Book value: 1034677000
P/B ratio: 2.3864078209721487
Market cap (USD): 2469161284.98
Debt to equity: 0.04091035173295628
Current ratio: 4.7718405342507335
Quick ratio: 3.1073155924314477
Effective tax rate (%): 13.0279423359301
Interest coverage ratio: 22.243661446681582
COGS to revenue (%): 55.08624059648554
R&D to revenue (%): 12.985907838407337
SG&A to revenue (%): 17.707568577721418
Free cash flow (dilution-adjusted): 86237000
Buyback yield (%): 4.903729891463155
Retained earnings: 503539000
Inventory turnover: 1.4048205221725782
Receivables turnover: 4.980134022637836
Capitalized R&D asset: 211620300
ROCI (R&D-adjusted, %): 9.051453781166975
Rosenberg metric: -0.7375186024247135
FCF margin (%): 10.277957876069069
Revenue growth (%): -17.56785035343587
Rule of 40 score: -7.2898924773668
Financial ratios for ADCT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.2
Shares outstanding: 127191158
Market cap (USD): 2569261391.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ADCT — annual report dated 2022-12-31
Total revenue: 228160869.56521738
Gross profit: 224572826.0869565
Operating income: -133681521.73913042
Net income: -170791304.3478261
Capital expenditures: 746739.1304347826
Operating cash flow: -150338043.47826087
Depreciation & amortization: 2595652.1739130435
Net tangible assets: 86359782.60869564
Owner earnings: -168942391.30434784
Return on net tangible assets (%): -195.62623503794796
Buffett classification: The Gruesome
Stock price: 3.84
Shares outstanding: 127191158
Book value: 86359782.60869569
P/B ratio: 5.655572906349823
Market cap (USD): 488414046.71999997
Debt to equity: 1.4773256472542817
Current ratio: 5.308583214342376
Quick ratio: 5.161241899461794
Interest coverage ratio: -3.3483161362336986
COGS to revenue (%): 1.5725937077195724
R&D to revenue (%): 88.82796272652782
SG&A to revenue (%): 68.36042456695314
Free cash flow (dilution-adjusted): -204695652.17391306
Buyback yield (%): 0.04918314551302425
Retained earnings: -1190672826.0869565
Inventory turnover: 0.27342002816201444
Receivables turnover: 2.8765948116374997
Capitalized R&D asset: 202670652.17391303
ROCI (R&D-adjusted, %): 0.22131635361572016
FCF margin (%): -89.71549440707359
Rule of 40 score: -89.71549440707359
Financial ratios for ADCT — annual report dated 2023-12-31
Total revenue: 82807142.85714287
Gross profit: 79796428.57142857
Operating income: -196489285.71428573
Net income: -285777380.95238096
Capital expenditures: 3828571.4285714286
Operating cash flow: -141292857.14285713
Depreciation & amortization: 3889285.7142857146
Net tangible assets: -176486904.76190478
Owner earnings: -285716666.6666666
Buffett classification: The Gruesome
Stock price: 1.66
Shares outstanding: 127191158
Book value: -176486904.76190472
Market cap (USD): 211137322.28
Debt to equity: -0.838973618709064
Current ratio: 4.969572927441998
Quick ratio: 4.730515738140979
Interest coverage ratio: -3.5628926065839184
COGS to revenue (%): 3.6358147157767617
R&D to revenue (%): 182.76402426751775
SG&A to revenue (%): 152.22979384111102
Free cash flow (dilution-adjusted): -161186904.76190475
Buyback yield (%): 0
Retained earnings: -1589847619.047619
Inventory turnover: 0.1563330654633121
Receivables turnover: 2.7622111031689305
Capitalized R&D asset: 287131003.62318844
ROCI (R&D-adjusted, %): -25.941116654754936
Rosenberg metric: -0.714343176787601
FCF margin (%): -194.65338278846426
Revenue growth (%): -63.70668510558366
Rule of 40 score: -258.3600678940479
Financial ratios for ADCT — quarterly report dated 2024-09-30
Capital expenditures: 257142.85714285716
Buffett classification: The Gruesome
Stock price: 3.15
Shares outstanding: 127191158
Market cap (USD): 400652147.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ADCT — quarterly report dated 2024-12-31
Capital expenditures: 100000
Buffett classification: The Gruesome
Stock price: 1.99
Shares outstanding: 127191158
Market cap (USD): 253110404.42
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ADCT — annual report dated 2024-12-31
Total revenue: 78707777.77777778
Gross profit: 72097777.77777778
Operating income: -143990000
Net income: -175384444.44444445
Capital expenditures: 963333.3333333333
Operating cash flow: -137594444.44444445
Depreciation & amortization: 3640000
Net tangible assets: -225157777.77777776
Owner earnings: -172707777.7777778
Buffett classification: The Gruesome
Stock price: 1.99
Shares outstanding: 127191158
Book value: -225157777.77777785
Market cap (USD): 253110404.42
Debt to equity: -0.6069719011853415
Current ratio: 3.619455939554362
Quick ratio: 3.5914824342293303
Interest coverage ratio: -2.5809284818067755
COGS to revenue (%): 8.398153507347855
R&D to revenue (%): 154.7679884805963
SG&A to revenue (%): 121.27701624857067
Free cash flow (dilution-adjusted): -145855555.55555555
Buyback yield (%): 0
Retained earnings: -1659242222.222222
Inventory turnover: 2.6428254109284763
Receivables turnover: 3.4867592045678286
Capitalized R&D asset: 290094676.3285024
ROCI (R&D-adjusted, %): -32.37311109205642
Rosenberg metric: -0.05086934063312014
FCF margin (%): -185.31276028064428
Revenue growth (%): -4.9504969473916365
Rule of 40 score: -190.2632572280359
Financial ratios for ADCT — quarterly report dated 2025-03-31
Total revenue: 26173863.636363637
Gross profit: 23831818.181818184
Operating income: -32026136.363636363
Net income: -43865909.09090909
Capital expenditures: 300000
Operating cash flow: -64015909.09090909
Depreciation & amortization: 521590.9090909091
Net tangible assets: -270707954.54545456
Owner earnings: -43644318.18181819
Buffett classification: The Gruesome
Stock price: 1.41
Shares outstanding: 127191158
Book value: -270707954.54545456
Market cap (USD): 179339532.78
Debt to equity: -0.5167343203636928
Current ratio: 4.463940893518358
Quick ratio: 4.162058345156937
Interest coverage ratio: -2.304415372035977
COGS to revenue (%): 8.94803108583337
R&D to revenue (%): 125.59371336777667
SG&A to revenue (%): 89.0374679807233
Free cash flow (dilution-adjusted): -67067045.45454546
Buyback yield (%): 0
Retained earnings: -1740818181.8181818
Inventory turnover: 0.11812919126497393
Receivables turnover: 0.725174737107235
Capitalized R&D asset: 32872727.272727273
ROCI (R&D-adjusted, %): -3.6514782789503424
FCF margin (%): -256.2367038596796
Rule of 40 score: -256.2367038596796
Financial ratios for ADCT — quarterly report dated 2025-06-30
Total revenue: 23548750
Gross profit: 22503750
Operating income: -38218750
Net income: -70807500
Capital expenditures: 0
Operating cash flow: -30108750
Depreciation & amortization: 1477500
Net tangible assets: -248980000
Owner earnings: -69330000
Buffett classification: The Gruesome
Stock price: 2.68
Shares outstanding: 127191158
Book value: -248980000
Market cap (USD): 340872303.44
Debt to equity: -0.590022290947064
Current ratio: 4.934287925696594
Quick ratio: 4.659318885448917
Interest coverage ratio: -2.352465953681619
COGS to revenue (%): 4.437602845161632
R&D to revenue (%): 159.7218536015712
SG&A to revenue (%): 100.69005785869737
Free cash flow (dilution-adjusted): -32372500
Buyback yield (%): 0
Retained earnings: -1985707500
Inventory turnover: 0.04706412205145527
Receivables turnover: 0.7194851817904063
Capitalized R&D asset: 59637227.27272727
ROCI (R&D-adjusted, %): -6.328490211958348
Rosenberg metric: -0.04040030420353987
FCF margin (%): -137.4701417272679
Revenue growth (%): -10.02952285850736
Rule of 40 score: -147.49966458577526
Financial ratios for ADCT — quarterly report dated 2025-09-30
Total revenue: 20533750
Gross profit: 19031250
Operating income: -37907500
Net income: -51207500
Capital expenditures: 0
Operating cash flow: -37037500
Depreciation & amortization: 152500
Net tangible assets: -297728750
Owner earnings: -51055000
Buffett classification: The Gruesome
Stock price: 4
Shares outstanding: 127191158
Book value: -297728750
Market cap (USD): 508764632
Debt to equity: -0.49233572505174594
Current ratio: 4.628150989620269
Quick ratio: 4.337357359293405
Interest coverage ratio: -2.2644862604540026
COGS to revenue (%): 7.317221647288001
R&D to revenue (%): 163.16430267242953
SG&A to revenue (%): 115.74846289645096
Free cash flow (dilution-adjusted): -39537500
Buyback yield (%): 0
Retained earnings: -2036915000
Inventory turnover: 0.06662232568451391
Receivables turnover: 0.7167728423073567
Capitalized R&D asset: 69552125
ROCI (R&D-adjusted, %): -11.02973892510154
Rosenberg metric: -0.09232303090727817
FCF margin (%): -192.54885249893468
Revenue growth (%): -12.803227347523755
Rule of 40 score: -205.35207984645842
Financial ratios for ADCT — quarterly report dated 2025-12-31
Total revenue: 29187341.7721519
Gross profit: 27036708.860759493
Operating income: -22940506.329113923
Net income: -8112658.2278481005
Capital expenditures: 834177.2151898734
Operating cash flow: -39396202.531645566
Depreciation & amortization: 143037.9746835443
Net tangible assets: -235232911.39240506
Owner earnings: -8803797.46835443
Buffett classification: The Gruesome
Stock price: 3.53
Shares outstanding: 127191158
Book value: -235232911.3924051
Market cap (USD): 448984787.73999995
Debt to equity: -0.629723301441071
Current ratio: 4.366047631942762
Quick ratio: 4.306415062069751
Interest coverage ratio: -1.3925772245274322
COGS to revenue (%): 7.368375401162288
R&D to revenue (%): 78.86200017347558
SG&A to revenue (%): 92.99158643420938
Free cash flow (dilution-adjusted): -40248101.26582278
Buyback yield (%): 0
Retained earnings: -2070811392.4050632
Inventory turnover: 0.4060707456978968
Receivables turnover: 0.7919085070577326
Capitalized R&D asset: 57877359.01898734
ROCI (R&D-adjusted, %): -8.27813032505588
Rosenberg metric: 0.23894217395842235
FCF margin (%): -137.89574117442967
Revenue growth (%): 42.143260593666035
Rule of 40 score: -95.75248058076363
Financial ratios for ADCT — annual report dated 2025-12-31
Total revenue: 102983544.30379747
Gross profit: 95644303.79746835
Operating income: -135705063.29113925
Net income: -180535443.0379747
Capital expenditures: 500000
Operating cash flow: -178701265.8227848
Depreciation & amortization: 2374683.544303797
Net tangible assets: -235232911.39240506
Owner earnings: -178660759.49367088
Buffett classification: The Gruesome
Stock price: 3.53
Shares outstanding: 127191158
Book value: -235232911.3924051
Market cap (USD): 448984787.73999995
Debt to equity: -0.629723301441071
Current ratio: 4.366047631942762
Quick ratio: 4.306415062069751
Interest coverage ratio: -2.0763271551139777
COGS to revenue (%): 7.126614796514128
R&D to revenue (%): 127.83780129552464
SG&A to revenue (%): 98.24968963949014
Free cash flow (dilution-adjusted): -187775949.36708862
Buyback yield (%): 0
Retained earnings: -2070811392.4050632
Inventory turnover: 1.3857552581261952
Receivables turnover: 2.7941408798983414
Capitalized R&D asset: 263210326.511955
ROCI (R&D-adjusted, %): -23.822071141373872
Rosenberg metric: 0.193298308152851
FCF margin (%): -182.33587767493887
Revenue growth (%): 30.842906776709523
Rule of 40 score: -151.49297089822934
Financial ratios for ALL.AX — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 31.151079136690647
Shares outstanding: 599454257
Market cap (USD): 18673646998.633095
Buyback yield (%): 0
Capitalized R&D asset: 379568345.323741
Rule of 40 score: 0
Financial ratios for ALL.AX — annual report dated 2022-09-30
Total revenue: 3619285714.285714
Gross profit: 1999870129.8701298
Operating income: 710259740.2597402
Net income: 615909090.9090909
Capital expenditures: 135194805.1948052
Depreciation & amortization: 323376623.3766234
Net tangible assets: 1384090909.090909
Owner earnings: 804090909.090909
Return on net tangible assets (%): 58.09523809523809
Capex to operating income (%): 19.03455842018651
Buffett classification: The Great
Stock price: 20.064935064935064
P/E ratio: 19.528873527991564
Shares outstanding: 599454257
Book value: 3910844155.844156
P/B ratio: 3.0755535791754527
Market cap (USD): 12028010741.103895
Debt to equity: 0.4624337921530211
Current ratio: 3.1753000151906425
Quick ratio: 2.9567826219049063
Effective tax rate (%): 22.829712797982264
Interest coverage ratio: 4.292778649921507
COGS to revenue (%): 44.7440658808332
SG&A to revenue (%): 14.738862873853991
Free cash flow (dilution-adjusted): 634545454.5454545
Buyback yield (%): 1.998581607248782
Retained earnings: 2482467532.4675326
Inventory turnover: 8.668404588112617
Receivables turnover: 6.618024222274994
Capitalized R&D asset: 254310791.3669065
ROCI (R&D-adjusted, %): 9.776096098760576
FCF margin (%): 17.53233937958627
Rule of 40 score: 17.53233937958627
Financial ratios for ALL.AX — annual report dated 2023-09-30
Total revenue: 4035705128.205128
Gross profit: 2275128205.128205
Operating income: 845128205.1282051
Net income: 932115384.6153846
Capital expenditures: 225641025.64102563
Depreciation & amortization: 313012820.5128205
Net tangible assets: 1747179487.1794872
Owner earnings: 1019487179.4871794
Return on net tangible assets (%): 58.35045494570002
Capex to operating income (%): 26.699029126213592
Buffett classification: The Good
Stock price: 24.96153846153846
P/E ratio: 16.05305602611925
Shares outstanding: 599454257
Book value: 4311602564.102564
P/B ratio: 3.4704730479148393
Market cap (USD): 14963300492.03846
Debt to equity: 0.3987303192042937
Current ratio: 2.977735577237902
Quick ratio: 2.775391264488246
Effective tax rate (%): 12.948994252873563
Interest coverage ratio: 8.577748861418346
COGS to revenue (%): 43.62501389837508
SG&A to revenue (%): 14.64968152866242
Free cash flow (dilution-adjusted): 863076923.076923
Buyback yield (%): 2.22553052844195
Retained earnings: 3147243589.7435894
Inventory turnover: 8.888349514563107
Receivables turnover: 6.328608765581021
Capitalized R&D asset: 125257553.95683454
ROCI (R&D-adjusted, %): 11.688781222067602
FCF margin (%): 21.38602538240386
Revenue growth (%): 11.505568965604493
Rule of 40 score: 32.891594348008354
Financial ratios for ALL.AX — annual report dated 2024-09-30
Total revenue: 4554206896.551724
Gross profit: 2668827586.206897
Operating income: 988344827.5862069
Net income: 898896551.7241379
Capital expenditures: 289103448.2758621
Depreciation & amortization: 410068965.5172414
Net tangible assets: 643517241.3793104
Owner earnings: 1019862068.9655172
Return on net tangible assets (%): 158.4824777622977
Capex to operating income (%): 29.25127346312191
Buffett classification: The Good
Stock price: 39.15172413793104
P/E ratio: 26.109420108861446
Shares outstanding: 599454257
Book value: 4330965517.24138
P/B ratio: 5.419038228298222
Market cap (USD): 23469667703.372417
Debt to equity: 0.38339782480612744
Current ratio: 1.5373209986060068
Quick ratio: 1.3612976809022936
Effective tax rate (%): 24.51059886482103
Interest coverage ratio: 8.727771010962242
COGS to revenue (%): 41.39863104973045
SG&A to revenue (%): 15.055424314010537
Free cash flow (dilution-adjusted): 876620689.6551725
Buyback yield (%): 2.7354456318431355
Retained earnings: 3976137931.034483
Inventory turnover: 9.840892728581714
Receivables turnover: 6.058904486650152
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.42483839911979
FCF margin (%): 19.248591677266948
Revenue growth (%): 12.847860581360138
Rule of 40 score: 32.09645225862708
Financial ratios for ALL.AX — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 643517241.3793104
Buffett classification: The Gruesome
Stock price: 39.15172413793104
Shares outstanding: 599454257
Book value: 4330965517.24138
P/B ratio: 5.419038228298222
Market cap (USD): 23469667703.372417
Debt to equity: 0.38339782480612744
Current ratio: 1.5373209986060068
Quick ratio: 1.3612976809022936
Buyback yield (%): 0
Retained earnings: 3976137931.034483
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALTHO.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.636363636363637
Shares outstanding: 1008800760
Market cap (USD): 13756374000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALTHO.PA — annual report dated 2022-12-31
Total revenue: 32895268.085106384
Gross profit: 1756400
Operating income: -7755305.319148936
Net income: 6546464.893617022
Capital expenditures: 156403.19148936172
Operating cash flow: -8257078.723404256
Depreciation & amortization: 6840698.936170213
Net tangible assets: 11757523.40425532
Owner earnings: 13230760.638297874
Return on net tangible assets (%): 112.53016628918091
Buffett classification: The Gruesome
Stock price: 3.765957446808511
P/E ratio: 580.3285889720893
Shares outstanding: 1008800760
Book value: 12157189.36170213
P/B ratio: 312.4982774748993
Market cap (USD): 3799100734.4680853
Debt to equity: 2.2936907659402657
Current ratio: 3.9521163196403357
Quick ratio: 2.8120496549551026
Interest coverage ratio: -6.135572835439267
COGS to revenue (%): 94.66063022968575
Free cash flow (dilution-adjusted): -8413481.914893618
Buyback yield (%): 0
Retained earnings: -8377492.55319149
Inventory turnover: 2.3193976301055628
Receivables turnover: 2.7439430630220674
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -20.739971643941562
FCF margin (%): -25.576571965081186
Rule of 40 score: -25.576571965081186
Financial ratios for ALTHO.PA — annual report dated 2023-12-31
Total revenue: 31465704.444444444
Gross profit: -916225.5555555555
Operating income: 2369337.7777777775
Net income: 1194584.4444444445
Capital expenditures: 544743.3333333334
Operating cash flow: -2520262.222222222
Depreciation & amortization: 844761.1111111111
Net tangible assets: 16293633.333333332
Owner earnings: 1494602.222222222
Return on net tangible assets (%): 9.172921666063157
Capex to operating income (%): 22.991374992731213
Buffett classification: The Great
Stock price: 1.0555555555555556
P/E ratio: 891.3938663933344
Shares outstanding: 1008800760
Book value: 16748486.666666657
P/B ratio: 63.57859476259152
Market cap (USD): 1064845246.6666667
Debt to equity: 1.5793034169986047
Current ratio: 2.4582255776071498
Quick ratio: 1.9353528314102912
Effective tax rate (%): 18.842678174225576
Interest coverage ratio: 1.8102608421041906
COGS to revenue (%): 102.91182279797115
Free cash flow (dilution-adjusted): -3065005.5555555555
Buyback yield (%): 0
Retained earnings: 1116748.8888888888
Inventory turnover: 2.2536454265524886
Receivables turnover: 1.311006621387718
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.692305162508548
FCF margin (%): -9.740781621358902
Revenue growth (%): -4.345803283813903
Rule of 40 score: -14.086584905172806